Protai
Israel
- Tel Aviv
- 05/01/2022
- Seed
- $8,000,000
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- Industry Biotechnology Research
- Website https://www.protai.bio/
- LinkedIn https://www.linkedin.com/company/protai-bio/about/
Related People
Eran SegerCo Founder
Israel -
Tel Aviv
My passion lays at the intersection of cutting edge technology and innovative biology. Building on over 15 years of experience in various leadership positions in the High-tech & Cyber field together with my knowledge and passion for the computational-bio space, I co-founded Protai a tech driven drug development computational biology startup.
Protai has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are discovered.
Niobium Microsystems | $23,000,000 | (Dec 10, 2025)
Corma | $4,069,327 | (Dec 10, 2025)
Scowtt | $12,000,000 | (Dec 10, 2025)
AnySignal | $24,000,000 | (Dec 10, 2025)
AllScale | $5,000,000 | (Dec 10, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)
Opine | $5,000,000 | (Dec 10, 2025)
Rotostitch | $1,000,000 | (Dec 10, 2025)
Lin Health | $11,000,000 | (Dec 10, 2025)
Diald AI | $3,750,000 | (Dec 10, 2025)
Tuhk Inc. | $6,000,000 | (Dec 10, 2025)